Anti-stress action of several orally-given β-glucans

Vaclav Vetvicka1, Zuzana Vancikova

  • 1University of Louisville, Department of Pathology, KY, USA. Vaclav.vetvicka@louisville.edu

Abstract

Insights

Certain beta-glucans can counteract stress-induced immune suppression. Glucan #300 effectively restored phagocytic activity and cytokine levels (IL-6, IL-12) in mice exposed to cold or restraint stress.

Area of Science:

  • Immunology
  • Stress Physiology
  • Nutritional Science

Background:

  • Beta-glucans are recognized for their immunomodulatory properties.
  • Emerging research indicates glucans can mitigate stress-induced immunosuppression.

Purpose of the Study:

  • To compare the efficacy of four distinct beta-glucan types in counteracting immune suppression induced by cold and restraint stress.
  • To evaluate the impact of beta-glucans on stress markers and immune cell activity.

Main Methods:

  • Mice were exposed to restraint and cold stress protocols.
  • Dietary administration of four different beta-glucans was assessed over 14 days.
  • Phagocytic activity, corticosterone levels, and cytokine (IL-6, IL-12) secretion were measured.

Main Results:

  • Cold stress reduced phagocytic activity by 38%; only glucan #300 normalized this function.
  • Stress significantly increased corticosterone levels, an effect partially blocked by glucan administration.
  • Glucan #300 maintained IL-6 and IL-12 secretion above control levels, unlike other glucans.

Conclusions:

  • While all tested beta-glucans aided immune recovery from stress, their effectiveness varied significantly.
  • Glucan #300 demonstrated superior ability to restore immune function under stress.
  • Results suggest beta-glucans may exert their effects by modulating corticosterone and enhancing cytokine production.

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Stress Prevention and Stress Management Techniques III01:25

Stress Prevention and Stress Management Techniques III

Regular exercise and meditation serve as essential tools in managing stress and promoting physical and mental well-being.
The Role of Exercise in Stress Management
Regular physical activity is essential for reducing stress and promoting cardiovascular health. Exercise strengthens the heart, enhances blood flow, keeps blood vessels flexible, and helps lower blood pressure, all of which reduce the body's stress response. Research shows that adults who exercise regularly have nearly half the risk...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...